Menu
Recruiting NCT06022653

Asan Aorta and Peripheral Registry

— Observational Aorta Disease Peripheral Artery Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Treatment.
Who it may be relevant to
Registry conditions: Aorta Disease, Peripheral Artery Disease. Basic parameters: from 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Evaluation of Patients Underwent Revascularization of Aorta or Peripheral Artery at the Peripheral Vascular Disease Center, Asan Medical Center; A Single Center, Retrospective/Prospective Observational Study.

Overview

The purpose of this study is to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at Asan Medical Center.

Detailed description

This study is a single center retrospective and prospective observational study to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at asan medical center.

Data will be collected on approximately 6,000 subjects in asan medical center. Individuals will be followed up at 1, 6, and 12 months, 3, 5years up to 10 years by telephone call or hospital visit.

Data collected during all follow-up visits will include a composite of major adverse limb events, or death from any cause.

Interventions

  • Other Treatment
    EVAR,TEVAR,PTA

Primary outcome measures

  • Rate of death from any cause [Time frame: 10years]
  • Rate of major Adverse Limb Events [Time frame: 10years]
Secondary outcome measures (8)
  • Rate of death from all cause including cardiovascular death [Time frame: 10years]
  • Rate of stroke [Time frame: 10years]
  • Rate of myocardial Infarction [Time frame: 10years]
  • Rate of vascular complication [Time frame: 10years]
  • Rate of bleeding [Time frame: 10years]
  • Success of the procedure [Time frame: 10years]
  • Rate of limb amputation [Time frame: 10years]
  • Rate of reintervention of aorta , reintervention of index limb or non-index limb [Time frame: 10years]

Eligibility criteria

Inclusion criteria

  • Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center
  • Patients with aortic and peripheral artery disease are defined as:

Thoacic aorta disease/ abdominal aorta disease

  • Aneurysm
  • Aortic dissection
  • Penetrating aortic ulcer

Peripheral artery occlusive disease

  • Chronic Limb-Threatening Ischemia
  • Claudication
  • Acute limb ischemia

Exclusion criteria

  • For prospective cohort, not agreeing to participate with written informed consent form

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

South Korea · 1 center
  • Asan Medical Center — Seoul

Identifiers

NCT: NCT06022653 · 2023-1234

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗